China Universal Asset Management Co., Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 76,650 shares of LXRX stock, worth $54,421. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,650
Previous 69,527
10.24%
Holding current value
$54,421
Previous $109,000
48.62%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding LXRX
# of Institutions
133Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$96.7 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$27.6 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.02 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$6.38 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $134M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...